First Time Loading...

Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 1.97 EUR 0.92% Market Closed
Updated: May 9, 2024
Section:
 

Wall Street
Price Targets

ORY Price Targets Summary
Oryzon Genomics SA

Wall Street analysts forecast ORY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORY is 6.46 EUR with a low forecast of 2.53 EUR and a high forecast of 12.6 EUR.

ORY Lowest Forecast
Wall Street Target
2.53 EUR
28% Upside
ORY Average Forecast
Wall Street Target
6.46 EUR
228% Upside
ORY Highest Forecast
Wall Street Target
12.6 EUR
540% Upside
Lowest
Price Target
2.53 EUR
28% Upside
Average
Price Target
6.46 EUR
228% Upside
Highest
Price Target
12.6 EUR
540% Upside
Oryzon Genomics SA Competitors:
Price Targets
MRNA
Moderna Inc
15% Upside
FHTX
Foghorn Therapeutics Inc.
135% Upside
603387
Getein Biotech Inc
280% Upside
Z
ZURA
Zura Bio Ltd
290% Upside
MRNA
Moderna Inc
15% Upside
FHTX
Foghorn Therapeutics Inc.
135% Upside
603387
Getein Biotech Inc
280% Upside
Z
ZURA
Zura Bio Ltd
290% Upside
INCY
Incyte Corp
38% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
7% Upside
ATORX
Alligator Bioscience AB
150% Upside
CIR
Circassia Group PLC
29% Upside

Revenue
Forecast

Revenue Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
What are analyst estimates?

See Also

Summary
ORY intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORY stock valuation using valuation multiples.
Wall Street Estimates
ORY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORY's stock price target?
Price Target
6.46 EUR

According to Wall Street analysts, the average 1-year price target for ORY is 6.46 EUR with a low forecast of 2.53 EUR and a high forecast of 12.6 EUR.

ALPHA SPREAD
Join more than 135,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.